Viewing Study NCT06522360


Ignite Creation Date: 2025-12-25 @ 2:07 AM
Ignite Modification Date: 2026-01-03 @ 11:20 PM
Study NCT ID: NCT06522360
Status: WITHDRAWN
Last Update Posted: 2025-04-24
First Post: 2024-07-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Brigatinib Plus Chemotherapy or Local Consolidation Therapy in ALK Positive Advanced Non-small Cell Lung Cancer (BrightStar-2)
Sponsor: M.D. Anderson Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module